Ani Pharmaceuticals (ANIP) Gross Profit (2012 - 2026)
Ani Pharmaceuticals' Gross Profit was $165.89 million in Q2 2026, up 21.3% from $136.76 million a year earlier and up 15.3% from the prior quarter.
Ani Pharmaceuticals (ANIP) Gross Profit (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ani Pharmaceuticals' Gross Profit was $590.98 million through Jun 30, 2026, up 29.5% year-over-year; for FY2025, it came in at $542.06 million, up 48.8% from FY2024.
- Gross Profit has now increased for four consecutive years, with a five-year compound annual growth rate of 34.9% (FY2020 to FY2025).
- In earlier years, Gross Profit was $364.17 million in FY2024 (+19.3%), $305.3 million in FY2023 (+71.9%), $177.6 million in FY2022 (+53.7%) and $115.53 million in FY2021 (-4.8%).
- The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q2 2012.
- Compared with a year earlier, Gross Profit has increased for 17 straight quarters, with growth averaging 35.2% over the last eight quarters.
- The best year-over-year quarter for Gross Profit over five years was Q1 2023 (growth of 128.7%); the worst was Q4 2021 (a decline of 17.4%).
- Per Business Quant data, ANIP's Gross Profit in the three quarters before Q2 2026 was $143.88 million (Q1 2026), $146.79 million (Q4 2025) and $134.42 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ani Pharmaceuticals | 1.73 Bn | 513.34 Mn | 165.89 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.89 Mn |
| Mar 31, 2026 | 143.88 Mn |
| Dec 31, 2025 | 146.79 Mn |
| Sep 30, 2025 | 134.42 Mn |
| Jun 30, 2025 | 136.76 Mn |
| Mar 31, 2025 | 124.09 Mn |
| Dec 31, 2024 | 110.29 Mn |
| Sep 30, 2024 | 85.26 Mn |
| Jun 30, 2024 | 80.34 Mn |
| Mar 31, 2024 | 88.27 Mn |
| Dec 31, 2023 | 78.23 Mn |
| Sep 30, 2023 | 83.73 Mn |
| Jun 30, 2023 | 74.26 Mn |
| Mar 31, 2023 | 69.08 Mn |
| Dec 31, 2022 | 57.91 Mn |
| Sep 30, 2022 | 50.93 Mn |
| Jun 30, 2022 | 38.56 Mn |
| Mar 31, 2022 | 30.21 Mn |
| Dec 31, 2021 | 27.03 Mn |
| Sep 30, 2021 | 27.65 Mn |
Ani Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ANIP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();